Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release

Morad, H.O.J., Luqman, S., Pinto, L.G., Cunningham, K.P., Vilar, B., Clayton, G., Shankar-Hari, M. and McNaughton, P.A. 2022. Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release. Scientific Reports. 12 (1), pp. 1-18. https://doi.org/10.1038/s41598-022-15214-6

TitleArtemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release
TypeJournal article
AuthorsMorad, H.O.J., Luqman, S., Pinto, L.G., Cunningham, K.P., Vilar, B., Clayton, G., Shankar-Hari, M. and McNaughton, P.A.
Abstract

Immune cell chemotaxis to the sites of pathogen invasion is critical for fighting infection, but in life-threatening conditions such as sepsis and Covid-19, excess activation of the innate immune system is thought to cause a damaging invasion of immune cells into tissues and a consequent excessive release of cytokines, chemokines and neutrophil extracellular traps (NETs). In these circumstances, tempering excessive activation of the innate immune system may, paradoxically, promote recovery. Here we identify the antimalarial compound artemisinin as a potent and selective inhibitor of neutrophil and macrophage chemotaxis induced by a range of chemotactic agents. Artemisinin released calcium from intracellular stores in a similar way to thapsigargin, a known inhibitor of the Sarco/Endoplasmic Reticulum Calcium ATPase pump (SERCA), but unlike thapsigargin, artemisinin blocks only the SERCA3 isoform. Inhibition of SERCA3 by artemisinin was irreversible and was inhibited by iron chelation, suggesting iron-catalysed alkylation of a specific cysteine residue in SERCA3 as the mechanism by which artemisinin inhibits neutrophil motility. In murine infection models, artemisinin potently suppressed neutrophil invasion into both peritoneum and lung in vivo and inhibited the release of cytokines/chemokines and NETs. This work suggests that artemisinin may have value as a therapy in conditions such as sepsis and Covid-19 in which over-activation of the innate immune system causes tissue injury that can lead to death.

JournalScientific Reports
Journal citation12 (1), pp. 1-18
ISSN2045-2322
Year2022
PublisherNature Publishing Group
Publisher's version
License
CC BY 4.0
File Access Level
Open (open metadata and files)
Digital Object Identifier (DOI)https://doi.org/10.1038/s41598-022-15214-6
Web address (URL)https://www.nature.com/articles/s41598-022-15214-6
Publication dates
PublishedJun 2022

Related outputs

In sepsis hydrogen peroxide release accompanies neutrophil chemotaxis to organs, artesunate prevents this neutrophil-mediated organ infiltration, cytokine storm and NET release
Morad, H. 2024. In sepsis hydrogen peroxide release accompanies neutrophil chemotaxis to organs, artesunate prevents this neutrophil-mediated organ infiltration, cytokine storm and NET release. International Conference on Vaccines and Immunology . Paris, France 17 - 18 Oct 2024 Scientific Collegium.

Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release
Morad, H.O.J., Luqman, S., Garcia Pinto, L., Cunningham, K., Vilar, B., Clayton, G., Shankar-Hari, M. and McNaughton, P.A. 2022. Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release. Scientific Reports. 2022 (12) 11078. https://doi.org/10.1038/s41598-022-15214-6

Repurposing the antimalarial compound artemisinin as a novel therapy for inflammatory conditions
Morad, H. 2022. Repurposing the antimalarial compound artemisinin as a novel therapy for inflammatory conditions. Drug Repurposing II. Woburn House, London, UK 10 - 11 May 2022 The Biochemical Society.

TRPM2 ion channels steer neutrophils towards a source of hydrogen peroxide
Hassan Morad, Suaib Luqman, Chun-Hsiang Tan and Peter McNaughton 2021. TRPM2 ion channels steer neutrophils towards a source of hydrogen peroxide. Dynamic Cell IV. 14 - 19 Mar 2021 The Biochemical Society.

Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug conjugates (ADcs)
Hoffmann, R.M., Mele, S., Cheung, A., Larcombe-Young, D., Bucaite, G., Sachouli, E., Zlatareva, I., Morad, H., Marlow, R., McDonnell, J.M., Figini, M., Lacy, K.E., Tutt, A.J.N., Spicer, J.F., Thurston, D.E., Karagiannis, S.N. and Crescioli, S. 2020. Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug conjugates (ADcs). Scientific Reports. 10 (1), pp. 1-11. https://doi.org/10.1038/s41598-020-65860-x

O30 Natural compounds affecting neutrophil migration
Hassan Morad, Suaib Luqman and Peter McNaughton 2017. O30 Natural compounds affecting neutrophil migration. ICMAN/ IUPHAR Natural Products. Aberdeen, Scotland 27 - 29 Sep 2017 Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2017.06.095

O30 Natural compounds affecting neutrophil migration
Morad, H., Luqman, S. and McNaughton, P. 2017. O30 Natural compounds affecting neutrophil migration. Biochemical Pharmacology. 139 (1), p. 119. https://doi.org/10.1016/j.bcp.2017.06.095

Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro
Morad, H. 2014. Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro. Royal Society of Medicine, Clinical Immunology and Allergy Conference. University of Cambridge Sep - Oct 2014 Royal Society of Medicine.

Permalink - https://westminsterresearch.westminster.ac.uk/item/w0xwx/artemisinin-inhibits-neutrophil-and-macrophage-chemotaxis-cytokine-production-and-net-release


Share this

Usage statistics

47 total views
55 total downloads
These values cover views and downloads from WestminsterResearch and are for the period from September 2nd 2018, when this repository was created.